Anders Rosholm

920 total citations
22 papers, 677 citations indexed

About

Anders Rosholm is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Anders Rosholm has authored 22 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Physiology. Recurrent topics in Anders Rosholm's work include Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (6 papers) and Blood properties and coagulation (4 papers). Anders Rosholm is often cited by papers focused on Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (6 papers) and Blood properties and coagulation (4 papers). Anders Rosholm collaborates with scholars based in United States, Denmark and Germany. Anders Rosholm's co-authors include Lars Hyldstrup, Lene Bæksgaard, Michael Grunkin, N. H. Bjarnason, Jan Trøst Jørgensen, P. B. Andersen, Ramin Tehranchi, Aida Inbal, Manuel Carção and Johannes Oldenburg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American Academy of Dermatology.

In The Last Decade

Anders Rosholm

21 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Rosholm United States 16 231 207 181 151 96 22 677
J P Crabbe United States 8 706 3.1× 91 0.4× 124 0.7× 250 1.7× 67 0.7× 13 877
Edoardo Cipolletta Italy 17 530 2.3× 115 0.6× 103 0.6× 247 1.6× 30 0.3× 84 886
B. Ostendorf Germany 8 548 2.4× 170 0.8× 44 0.2× 136 0.9× 25 0.3× 20 689
Thomas Kirchgesner Belgium 12 138 0.6× 33 0.2× 136 0.8× 155 1.0× 72 0.8× 45 423
Junming Ma China 17 125 0.5× 27 0.1× 93 0.5× 321 2.1× 128 1.3× 44 642
Giorgio Tamborrini Switzerland 18 795 3.4× 217 1.0× 175 1.0× 194 1.3× 26 0.3× 82 994
Kirsten van Langevelde Netherlands 13 185 0.8× 84 0.4× 26 0.1× 91 0.6× 168 1.8× 38 519
Hakan Özdemır Türkiye 17 66 0.3× 55 0.3× 248 1.4× 348 2.3× 81 0.8× 51 810
L. Mangnus Netherlands 13 407 1.8× 135 0.7× 109 0.6× 121 0.8× 5 0.1× 23 544
Luca Petricca Italy 16 294 1.3× 91 0.4× 15 0.1× 49 0.3× 85 0.9× 41 818

Countries citing papers authored by Anders Rosholm

Since Specialization
Citations

This map shows the geographic impact of Anders Rosholm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Rosholm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Rosholm more than expected).

Fields of papers citing papers by Anders Rosholm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Rosholm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Rosholm. The network helps show where Anders Rosholm may publish in the future.

Co-authorship network of co-authors of Anders Rosholm

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Rosholm. A scholar is included among the top collaborators of Anders Rosholm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Rosholm. Anders Rosholm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hillemanns, Peter, Michal Zikán, Frédéric Forget, et al.. (2025). Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study. Journal for ImmunoTherapy of Cancer. 13(1). e010827–e010827. 3 indexed citations
2.
Ochsenreither, Sebastian, Geòrgia Anguera, Sebastian M. Dieter, et al.. (2025). Induction of neoantigen-specific immune responses by VB10.NEO in combination with atezolizumab in heavily pretreated patients with advanced solid tumors: Final analysis of the phase 1b VB N-02 trial.. Journal of Clinical Oncology. 43(16_suppl). 2639–2639.
3.
Bieber, Thomas, Lisa A. Beck, Andrew Pink, et al.. (2021). Neutralizing interleukin-13 increases skin microbial diversity: results from a Phase 3, randomized, double-blind, placebo-controlled trial of tralokinumab in adult patients with atopic dermatitis. SKIN The Journal of Cutaneous Medicine. 5(6). s56–s56. 1 indexed citations
4.
Bieber, Thomas, Lisa A. Beck, Andrew Pink, et al.. (2021). 28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis. Journal of the American Academy of Dermatology. 85(3). AB177–AB177. 5 indexed citations
5.
Carção, Manuel, Carmen Altisent, Giancarlo Castaman, et al.. (2018). Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency. Thrombosis and Haemostasis. 118(3). 451–460. 22 indexed citations
6.
Neufeld, Ellis J., et al.. (2015). Safety update on the use of recombinant activated factor VII in approved indications. Blood Reviews. 29. S34–S41. 39 indexed citations
7.
Tiede, Andreas, Kagehiro Amano, Alice Ma, et al.. (2015). The use of recombinant activated factor VII in patients with acquired haemophilia. Blood Reviews. 29. S19–S25. 24 indexed citations
8.
Ljung, Rolf, Faraizah Abdul Karim, Kapil Saxena, et al.. (2013). 40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors. Journal of Thrombosis and Haemostasis. 11(7). 1260–1268. 27 indexed citations
9.
Williams, Michael D., et al.. (2013). Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients. Haemophilia. 20(1). 99–105. 15 indexed citations
10.
Møss, Judi, et al.. (2011). Safety and pharmacokinetics of a glycoPEGylated recombinant activated factor VII derivative: a randomized first human dose trial in healthy subjects. Journal of Thrombosis and Haemostasis. 9(7). 1368–1374. 22 indexed citations
11.
Inbal, Aida, Johannes Oldenburg, Manuel Carção, et al.. (2010). Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency. Blood. 116(21). 20–20. 2 indexed citations
12.
Böttcher, Joachim, Alexander Pfeil, Anders Rosholm, et al.. (2006). Computerized Digital Imaging Techniques Provided by Digital X-ray Radiogrammetry as New Diagnostic Tool in Rheumatoid Arthritis. Journal of Digital Imaging. 19(3). 279–288. 31 indexed citations
13.
Böttcher, Joachim, Alexander Pfeil, Anders Rosholm, et al.. (2005). Computerized Quantification of Joint Space Narrowing and Periarticular Demineralization in Patients With Rheumatoid Arthritis Based on Digital X-Ray Radiogrammetry. Investigative Radiology. 41(1). 36–44. 28 indexed citations
14.
Böttcher, Joachim, Alexander Pfeil, Anders Rosholm, et al.. (2005). Influence of Image-Capturing Parameters on Digital X-Ray Radiogrammetry. Journal of Clinical Densitometry. 8(1). 87–94. 32 indexed citations
15.
Shepherd, John, et al.. (2005). Metacarpal index and bone mineral density in healthy African-American women. Osteoporosis International. 16(12). 1621–1626. 16 indexed citations
16.
Böttcher, Joachim, Alexander Pfeil, Anders Rosholm, et al.. (2005). Digital x‐ray radiogrammetry combined with semiautomated analysis of joint space widths as a new diagnostic approach in rheumatoid arthritis: A cross‐sectional and longitudinal study. Arthritis & Rheumatism. 52(12). 3850–3859. 53 indexed citations
17.
Thodberg, Hans Henrik & Anders Rosholm. (2003). Application of the active shape model in a commercial medical device for bone densitometry. Image and Vision Computing. 21(13-14). 1155–1161. 18 indexed citations
18.
Rosholm, Anders, et al.. (2001). Estimation of Bone Mineral Density by Digital X-ray Radiogrammetry: Theoretical Background and Clinical Testing. Osteoporosis International. 12(11). 961–969. 147 indexed citations
19.
Thodberg, Hans Henrik & Anders Rosholm. (2001). Application of the Active Shape Model in a commercial medical device for bone densitometry. 6.1–6.10. 8 indexed citations
20.
Jørgensen, Jan Trøst, P. B. Andersen, Anders Rosholm, & N. H. Bjarnason. (2000). Digital X‐ray radiogrammetry: a new appendicular bone densitometric method with high precision. Clinical Physiology. 20(5). 330–335. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J P Crabbe Breakdown of academic impact, for papers by Edoardo Cipolletta Breakdown of academic impact, for papers by B. Ostendorf Breakdown of academic impact, for papers by Thomas Kirchgesner Breakdown of academic impact, for papers by Junming Ma Breakdown of academic impact, for papers by Giorgio Tamborrini Breakdown of academic impact, for papers by Kirsten van Langevelde Breakdown of academic impact, for papers by Hakan Özdemır Breakdown of academic impact, for papers by L. Mangnus Breakdown of academic impact, for papers by Luca Petricca
Rankless by CCL
2026